Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AstraZeneca

    NASDAQ: AZN · Real-Time Price · USD
    69.91
    -0.85 (-1.20%)
    At close: Jun 20, 2025, 3:59 PM
    70.14
    0.34%
    Pre-market: Jun 23, 2025, 05:39 AM EDT

    AstraZeneca Statistics

    Share Statistics

    AstraZeneca has 6.2B shares outstanding. The number of shares has increased by 0.02% in one year.

    Shares Outstanding

    n/a
    		 6.2B

    Shares Change (YoY)

    n/a
    		 0.02%

    Shares Change (QoQ)

    n/a
    		 0.02%

    Owned by Institutions (%)

    n/a
    		 16.57%

    Shares Floating

    n/a
    		 6.2B

    Failed to Deliver (FTD) Shares

    n/a
    		 16

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 6.92M, so 0.22% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.92M

    Short % of Shares Out

    n/a
    		 0.22%

    Short % of Float

    n/a
    		 0.22%

    Short Ratio (days to cover)

    n/a
    		 1.56

    Valuation Ratios

    The PE ratio is 57.74 and the forward PE ratio is 13.87. AstraZeneca's PEG ratio is -1.43.

    PE Ratio

    n/a
    		 57.74

    Forward PE

    n/a
    		 13.87

    PS Ratio

    n/a
    		 7.51

    Forward PS

    n/a
    		 5.9

    PB Ratio

    n/a
    		 9.96

    P/FCF Ratio

    n/a
    		 55.84

    PEG Ratio

    n/a
    		 -1.43
    Financial Ratio History

    Enterprise Valuation

    AstraZeneca has an Enterprise Value (EV) of 227.74B.

    EV / Sales

    n/a
    		 4.21

    EV / EBITDA

    n/a
    		 14.75

    EV / EBIT

    n/a
    		 19.2

    EV / FCF

    n/a
    		 31.3

    Financial Position

    The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.74.

    Current Ratio

    n/a
    		 0.93

    Quick Ratio

    n/a
    		 0.74

    Debt / Equity

    n/a
    		 0.74

    Debt / EBITDA

    n/a
    		 1.95

    Debt / FCF

    n/a
    		 4.14

    Interest Coverage

    n/a
    		 5.95

    Financial Efficiency

    Return on Equity is 17.25% and Return on Invested Capital is 10.3%.

    Return on Equity

    n/a
    		 17.25%

    Return on Assets

    n/a
    		 6.76%

    Return on Invested Capital

    n/a
    		 10.3%

    Revenue Per Employee

    n/a
    		 $573,414.63

    Profits Per Employee

    n/a
    		 $74,602.33

    Employee Count

    n/a
    		 94,300

    Asset Turnover

    n/a
    		 0.52

    Inventory Turnover

    n/a
    		 1.93

    Taxes

    Income Tax

    n/a
    		 1.65B

    Effective Tax Rate

    n/a
    		 18.99%

    Stock Price Statistics

    The stock price has increased by -11.37% in the last 52 weeks. The beta is 0.17, so AstraZeneca's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.17

    52-Week Price Change

    n/a
    		 -11.37%

    50-Day Moving Average

    n/a
    		 70.12

    200-Day Moving Average

    n/a
    		 71.7

    Relative Strength Index (RSI)

    n/a
    		 42.41

    Average Volume (20 Days)

    n/a
    		 5,393,966

    Income Statement

    In the last 12 months, AstraZeneca had revenue of 54.07B and earned 7.04B in profits. Earnings per share was 1.14.

    Revenue

    n/a
    		 54.07B

    Gross Profit

    n/a
    		 43.87B

    Operating Income

    n/a
    		 10B

    Net Income

    n/a
    		 7.04B

    EBITDA

    n/a
    		 15.44B

    EBIT

    n/a
    		 10.37B

    Earnings Per Share (EPS)

    n/a
    		 1.14
    Full Income Statement

    Balance Sheet

    The company has 5.49B in cash and 30.11B in debt, giving a net cash position of -24.63B.

    Cash & Cash Equivalents

    n/a
    		 5.49B

    Total Debt

    n/a
    		 30.11B

    Net Cash

    n/a
    		 -24.63B

    Retained Earnings

    n/a
    		 3.16B

    Total Assets

    n/a
    		 106.25B

    Working Capital

    n/a
    		 -2.99B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 11.86B and capital expenditures -4.59B, giving a free cash flow of 7.28B.

    Operating Cash Flow

    n/a
    		 11.86B

    Capital Expenditures

    n/a
    		 -4.59B

    Free Cash Flow

    n/a
    		 7.28B

    FCF Per Share

    n/a
    		 2.35
    Full Cash Flow Statement

    Margins

    Gross margin is 81.12%, with operating and profit margins of 18.5% and 13.01%.

    Gross Margin

    n/a
    		 81.12%

    Operating Margin

    n/a
    		 18.5%

    Pretax Margin

    n/a
    		 16.07%

    Profit Margin

    n/a
    		 13.01%

    EBITDA Margin

    n/a
    		 28.55%

    EBIT Margin

    n/a
    		 18.5%

    FCF Margin

    n/a
    		 13.45%

    Dividends & Yields

    AZN pays an annual dividend of $2.52, which amounts to a dividend yield of 2.07%.

    Dividend Per Share

    n/a
    		 $2.52

    Dividend Yield

    n/a
    		 2.07%

    Dividend Growth (YoY)

    n/a
    		 6.6%

    Payout Ratio

    n/a
    		 101.41%

    Earnings Yield

    n/a
    		 1.73%

    FCF Yield

    n/a
    		 3.58%
    Dividend Details

    Analyst Forecast

    The average price target for AZN is $95, which is 35.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $95

    Price Target Difference

    n/a
    		 35.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $5.7

    Lynch Upside

    n/a
    		 -91.85%

    Graham Number

    n/a
    		 25.92

    Graham Upside

    n/a
    		 -62.92%

    Stock Splits

    The last stock split was on Jul 27, 2015. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Jul 27, 2015

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 4.89

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist